SOUTH Africa’s healthcare landscape finds itself at a critical juncture. NHI causes uncertainty as the nation has deferred essential health financing reforms for nearly two decades. They were anticipating that the ambitious National Health Insurance (NHI) would...
A South African court has ruled in favour of Adcock Ingram and Zambon SPA. It ordered Cipla Medpro to stop using the trademark Furizome for its urinary tract infection (UTI) medication. The court found Furizome to be confusingly similar to the established Urizone...
ASPEN Pharmacare has issued a stark warning to investors. They are signalling a potential R2 billion plunge in core earnings for its 2025 financial year. This is due to the significant Aspen Pharmacare manufacturing dispute detailed this week. In a regulatory filing...
Health Minister Aaron Motsoaledi has confirmed that the Department of Health will proceed with its planned R65.9 million NHI advertising campaign. This decision comes despite facing a severe funding shortfall for critical HIV/AIDS programmes. The Minister cited the...
Eli Lilly has announced promising results from a Phase 3 trial of its oral drug, orforglipron. The trial demonstrated significant efficacy in reducing weight and blood sugar levels in patients with type 2 diabetes. Significant Weight Loss and Blood Sugar Control with...
